Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Long term trends introduce a potential bias when evaluating the impact of the pneumococcal conjugate vaccination programme in England and Wales.
FLASCHE, S; Slack, M; MILLER, E;
2011
Euro surveillance, (2011).16 20 10.2807/ese.16.20.19868-en.
Long term trends introduce a potential bias when evaluating the impact of the pneumococcal conjugate vaccination programme in England and Wales.
FLASCHE, S; Slack, M; Miller, E;
2011
EUROSURVEILLANCE, (2011).16 20(20), Art.No. ARTN 19868, 13-18.
Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools.
Chaiyakunapruk, N; Somkrua, R; Hutubessy, R; Henao, AM; Hombach, J; Melegaro, A; EDMUNDS, JW; Beutels, P;
2011
BMC medicine, (2011).9 1 10.1186/1741-7015-9-53.
Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models.
JIT, M; Demarteau, N; Elbasha, E; Ginsberg, G; Kim, J; Praditsitthikorn, N; Sinanovic, E; Hutubessy, R;
2011
BMC medicine, (2011).9 1 10.1186/1741-7015-9-54.
Response to comment on article by Jit et al. 'The cost effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe'.
JIT, M; Bilcke, J; Mangen, M-JJ; Salo, H; Melliez, H; EDMUNDS, WJ; Yazdanpanah, Y; Beutels, P;
2011
Vaccine, (2011).29 21 10.1016/j.vaccine.2011.02.104.
Performance of the BioPlex 2200 multiplexing immunoassay platform for the detection of herpes simplex virus type 2 specific antibodies in African settings.
LeGoff, J; Grésenguet, G; Gody, C; Longo, JD D; Khonde, N; WEISS, HA; MAYAUD, P; Bélec, L; ANRS 12-12 Study Group,;
2011
Clinical and vaccine immunology, (2011).18 7 10.1128/CVI.05003-11.
Selection and quantification of infection endpoints for trials of vaccines against intestinal helminths.
ALEXANDER, N; CUNDILL, B; Sabatelli, L; Bethony, JM; Diemert, D; Hotez, P; SMITH, PG; RODRIGUES, LC; BROOKER, S;
2011
Vaccine, (2011).29 20 10.1016/j.vaccine.2011.03.026.
Human saliva as a source of anti-malarial antibodies to examine population exposure to Plasmodium falciparum.
Estévez, PT; Satoguina, J; NWAKANMA, DC; West, S; CONWAY, DJ; DRAKELEY, CJ;
2011
Malaria journal, (2011).10 1 10.1186/1475-2875-10-104.
Pneumococcal glycoconjugate vaccines produce antibody responses that strongly correlate with function.
Licciardi, PV; Balloch, A; Russell, FM; Nahm, MH; MULHOLLAND, K; Tang, ML K;
2011
Nature reviews Drug discovery, (2011).10 5 10.1038/nrd3012-c1.
T cell responses to the RTS,S/AS01(E) and RTS,S/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian children.
Ansong, D; ASANTE, KP; Vekemans, J; Owusu, SK; Owusu, R; Brobby, NA W; DOSOO, D; Osei-Akoto, A; Osei-Kwakye, K; Asafo-Adjei, E; Boahen, KO; Sylverken, J; Adjei, G; Sambian, D; Apanga, S; Kayan, K; Janssens, MH; Lievens, MJ J; Olivier, AC; Jongert, E; Dubois, P; Savarese, BM; Cohen, J; Antwi, S; GREENWOOD, BM; ... OWUSU-AGYEI, S.
2011
PloS one, (2011).6 4 10.1371/journal.pone.0018891.